Skip to content

Ethical Complexities and Best Practices in Informed Consent for Psychedelic Services: A Qualitative Study on Expert Perspectives

Christina Chwyl, Alissa Bazinet, Adie Wilson-Poe, Kim Hoffman, Kellie Pertl, Sara McCrimmon, Philip Korthuis, Jason B Luoma

February 19, 2026 preprint DOI: 10.31234/osf.io/mdz73_v2 via OpenAlex

Summary

AI-generated from the abstract

Informed consent for psychedelic-assisted services should be treated as an ongoing process rather than a one-time form, according to 36 experienced facilitators. They emphasized building a strong therapeutic relationship, centering client empowerment, and comprehensively conveying potential long-term psychological and social changes, including the possibility of disappointing experiences. Detailed consent around touch and boundaries is needed, with explicit pre-session agreements, maintained boundaries, and attention to subtle non-verbal cues. Facilitator training should cultivate deep respect for client agency and provide experiential learning in relational and boundary-setting skills. These recommendations aim to improve practitioner training, consent practices, and policy for regulated psychedelic services.

Study at a glance

Characteristics Qualitative study
Sample size 36
Population Experienced psychedelic facilitators with expertise in psilocybin-assisted experiences or other psychedelic field expertise
Citations 1
Key finding Informed consent in psychedelic-assisted services should be an ongoing process emphasizing therapeutic relationship, comprehensive risk/benefit disclosure, explicit touch and boundary protocols, and facilitator training focused on client agency and relational skills.

Abstract

Background: Informed consent in psychedelic-assisted services is ethically complex, difficult to implement, and remains largely unstudied and unstandardized. Objective: The current study sought expert recommendations from experienced psychedelic facilitators on what constitutes informed consent best practices for supervised psychedelic experiences across various settings. Methods: Participants with expertise in facilitating psilocybin-assisted experiences or other expertise in the psychedelic field were recruited with purposive sampling. Qualitative interviews on informed consent best practices and recommendations were analyzed using Thematic Analysis. Results: Participants (N = 36; 71% white; 56% heterosexual; 53% female) reported facilitating psilocybin services (64%) for a mean of 15.2 (SD = 13.1) years in clinical trial, licensed service center, underground, or ceremonial settings. Participants viewed informed consent as a process (Theme 1), necessitating a strong therapeutic relationship, centering client empowerment, and occurring as an ongoing process. Potential risks and benefits should be comprehensively conveyed (Theme 2), including potential long-term psychological and social changes, and the potential for disappointing experiences. Participants recommended detailed consent processes around touch and boundaries (Theme 3), including explicitly establishing boundaries prior to psychedelic administration, maintaining those boundaries throughout, and recognizing subtle non-verbal cues that may indicate lack of true consent. Within facilitator trainings (Theme 4), participants emphasized cultivating a deep respect for client agency, and experientially learning relational and boundary setting skills. Conclusions: Findings may inform practitioner training, consent practices in varied settings, and policy development for state-regulated psychedelic services.

Comments

No comments yet.

Log in to comment